Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Notable companies reporting before tomorrow's open » 13:21
01/31/23
01/31
13:21
01/31/23
13:21
TMO

Thermo Fisher

$563.16 /

-0.905 (-0.16%)

, TMUS

T-Mobile

$149.52 /

+2.6 (+1.77%)

, MO

Altria Group

$44.73 /

+0.24 (+0.54%)

, BSX

Boston Scientific

$45.97 /

+0.165 (+0.36%)

, HUM

Humana

$508.55 /

+23.49 (+4.84%)

, ABC

AmerisourceBergen

$167.82 /

+2.435 (+1.47%)

, FTV

Fortive

$67.51 /

+1.27 (+1.92%)

, DT

Dynatrace

$38.07 /

+0.03 (+0.08%)

, PTON

Peloton

$12.94 /

+0.43 (+3.44%)

, EAT

Brinker

$39.13 /

+0.53 (+1.37%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Thermo Fisher (TMO), consensus $5.19... T-Mobile (TMUS), consensus $1.10... Altria (MO), consensus $1.17... Boston Scientific (BSX), consensus 47c... Humana (HUM), consensus $1.46... AmerisourceBergen (ABC), consensus $2.63... Fortive (FTV), consensus 84c... Dynatrace (DT), consensus 21c... Peloton (PTON), consensus (64c)... Brinker (EAT), consensus 52c.

ShowHide Related Items >><<
TMUS T-Mobile
$149.52 /

+2.6 (+1.77%)

TMO Thermo Fisher
$563.16 /

-0.905 (-0.16%)

PTON Peloton
$12.94 /

+0.43 (+3.44%)

MO Altria Group
$44.73 /

+0.24 (+0.54%)

HUM Humana
$508.55 /

+23.49 (+4.84%)

EAT Brinker
$39.13 /

+0.53 (+1.37%)

DT Dynatrace
$38.07 /

+0.03 (+0.08%)

BSX Boston Scientific
$45.97 /

+0.165 (+0.36%)

ABC AmerisourceBergen
$167.82 /

+2.435 (+1.47%)

TMO Thermo Fisher
$563.16 /

-0.905 (-0.16%)

01/24/23 Barclays
Thermo Fisher price target raised to $630 from $570 at Barclays
01/03/23 Wells Fargo
Thermo Fisher price target lowered to $505 from $525 at Wells Fargo
12/13/22 Deutsche Bank
Thermo Fisher initiated with a Buy at Deutsche Bank
12/06/22 RBC Capital
Thermo Fisher initiated with an Outperform at RBC Capital
TMUS T-Mobile
$149.52 /

+2.6 (+1.77%)

01/17/23 KeyBanc
Cogent price target raised to $71 from $64 at KeyBanc
01/13/23 Truist
American Tower price target lowered to $275 from $325 at Truist
01/05/23 JPMorgan
T-Mobile remains a top pick after preannouncement at JPMorgan
01/03/23 Wolfe Research
T-Mobile downgraded to Peer Perform from Outperform at Wolfe Research
MO Altria Group
$44.73 /

+0.24 (+0.54%)

11/10/22 UBS
UBS downgrades Altria to Sell on consumer trade down risk
11/10/22 UBS
Altria Group downgraded to Sell from Neutral at UBS
11/02/22 Morgan Stanley
Philip Morris price target raised to $109 from $102 at Morgan Stanley
10/28/22 Stifel
Altria JV news trumps 'rare' EPS miss, says Stifel
BSX Boston Scientific
$45.97 /

+0.165 (+0.36%)

01/04/23 Barclays
Boston Scientific price target raised to $53 from $49 at Barclays
01/03/23 Stifel
Apollo Endosurgery downgraded to Hold from Buy at Stifel
12/22/22 Mizuho
Boston Scientific initiated with a Neutral at Mizuho
12/20/22 Citi
Boston Scientific resumed with a Buy at Citi
HUM Humana
$508.55 /

+23.49 (+4.84%)

07:09 Today JPMorgan
Medicare Advantage final rule more favorable than feared, says JPMorgan
01/30/23 Cowen
Evolent Health price target raised to $59 from $57 at Cowen
12/27/22 Piper Sandler
Piper views TriCare T-5 contract awards as neutral for Accolade
12/23/22 Wells Fargo
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
ABC AmerisourceBergen
$167.82 /

+2.435 (+1.47%)

08:17 Today UBS
AmerisourceBergen price target raised to $190 from $184 at UBS
06:33 Today Evercore ISI
AmerisourceBergen resumed with an Outperform at Evercore ISI
01/12/23 Argus
AmerisourceBergen price target raised to $190 from $170 at Argus
01/11/23 Baird
AmerisourceBergen price target raised to $199 from $195 at Baird
FTV Fortive
$67.51 /

+1.27 (+1.92%)

01/13/23 Mizuho
Fortive price target raised to $63 from $60 at Mizuho
12/09/22 Citi
Fortive price target raised to $77 from $73 at Citi
10/12/22 Morgan Stanley
Fortive upgraded to Overweight at Morgan Stanley on execution, resilience
10/12/22 Morgan Stanley
Fortive upgraded to Overweight from Equal Weight at Morgan Stanley
DT Dynatrace
$38.07 /

+0.03 (+0.08%)

01/10/23 Barclays
Dynatrace downgraded to Equal Weight from Overweight at Barclays
01/09/23 Truist
Dynatrace price target lowered to $45 from $50 at Truist
01/03/23 Wells Fargo
Dynatrace price target raised to $50 from $45 at Wells Fargo
12/15/22 Wedbush
Wedbush initiates Dynatrace with a Neutral and $35 price target
PTON Peloton
$12.94 /

+0.43 (+3.44%)

01/30/23 Citi
Peloton promotions drove improved traffic trends, says Citi
01/24/23 MKM Partners
MKM Partners positive on Peloton heading into earnings
01/24/23 Baird
Peloton downgraded to Neutral from Outperform at Baird
11/21/22 Cowen
Peloton downgraded to Market Perform from Outperform at Cowen
EAT Brinker
$39.13 /

+0.53 (+1.37%)

01/24/23 Deutsche Bank
Brinker price target raised to $38 from $34 at Deutsche Bank
01/05/23 Barclays
Brinker price target lowered to $30 from $31 at Barclays
12/21/22 Jefferies
Brinker downgraded to Hold from Buy at Jefferies
12/12/22 Goldman Sachs
Brinker downgraded to Sell from Neutral at Goldman Sachs
TMUS T-Mobile
$149.52 /

+2.6 (+1.77%)

TMO Thermo Fisher
$563.16 /

-0.905 (-0.16%)

PTON Peloton
$12.94 /

+0.43 (+3.44%)

MO Altria Group
$44.73 /

+0.24 (+0.54%)

HUM Humana
$508.55 /

+23.49 (+4.84%)

FTV Fortive
$67.51 /

+1.27 (+1.92%)

EAT Brinker
$39.13 /

+0.53 (+1.37%)

DT Dynatrace
$38.07 /

+0.03 (+0.08%)

BSX Boston Scientific
$45.97 /

+0.165 (+0.36%)

ABC AmerisourceBergen
$167.82 /

+2.435 (+1.47%)

  • 09
    Dec
  • 08
    Nov
TMUS T-Mobile
$149.52 /

+2.6 (+1.77%)

TMO Thermo Fisher
$563.16 /

-0.905 (-0.16%)

PTON Peloton
$12.94 /

+0.43 (+3.44%)

MO Altria Group
$44.73 /

+0.24 (+0.54%)

HUM Humana
$508.55 /

+23.49 (+4.84%)

ABC AmerisourceBergen
$167.82 /

+2.435 (+1.47%)

TMUS T-Mobile
$149.52 /

+2.6 (+1.77%)

TMO Thermo Fisher
$563.16 /

-0.905 (-0.16%)

PTON Peloton
$12.94 /

+0.43 (+3.44%)

MO Altria Group
$44.73 /

+0.24 (+0.54%)

HUM Humana
$508.55 /

+23.49 (+4.84%)

FTV Fortive
$67.51 /

+1.27 (+1.92%)

EAT Brinker
$39.13 /

+0.53 (+1.37%)

DT Dynatrace
$38.07 /

+0.03 (+0.08%)

BSX Boston Scientific
$45.97 /

+0.165 (+0.36%)

ABC AmerisourceBergen
$167.82 /

+2.435 (+1.47%)

TMUS T-Mobile
$149.52 /

+2.6 (+1.77%)

TMO Thermo Fisher
$563.16 /

-0.905 (-0.16%)

PTON Peloton
$12.94 /

+0.43 (+3.44%)

MO Altria Group
$44.73 /

+0.24 (+0.54%)

HUM Humana
$508.55 /

+23.49 (+4.84%)

BSX Boston Scientific
$45.97 /

+0.165 (+0.36%)

Recommendations
Medicare Advantage final rule more favorable than feared, says JPMorgan » 07:09
01/31/23
01/31
07:09
01/31/23
07:09
CNC

Centene

$74.70 /

-0.52 (-0.69%)

, HUM

Humana

$484.92 /

+3.39 (+0.70%)

, UNH

UnitedHealth

$485.76 /

-0.035 (-0.01%)

, CI

Cigna

$310.37 /

+2.085 (+0.68%)

, CVS

CVS Health

$87.06 /

-0.7 (-0.80%)

, MOH

Molina Healthcare

$302.77 /

+2.35 (+0.78%)

After the close last…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNH UnitedHealth
$485.76 /

-0.035 (-0.01%)

MOH Molina Healthcare
$302.77 /

+2.35 (+0.78%)

HUM Humana
$484.92 /

+3.39 (+0.70%)

CVS CVS Health
$87.06 /

-0.7 (-0.80%)

CNC Centene
$74.70 /

-0.52 (-0.69%)

CI Cigna
$310.37 /

+2.085 (+0.68%)

CNC Centene
$74.70 /

-0.52 (-0.69%)

12/23/22 Wells Fargo
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
12/23/22 Credit Suisse
TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
12/14/22 Argus
Centene price target raised to $99 from $95 at Argus
12/13/22 BofA
Centene downgraded to Underperform from Neutral at BofA
HUM Humana
$484.92 /

+3.39 (+0.70%)

01/30/23 Cowen
Evolent Health price target raised to $59 from $57 at Cowen
12/27/22 Piper Sandler
Piper views TriCare T-5 contract awards as neutral for Accolade
UNH UnitedHealth
$485.76 /

-0.035 (-0.01%)

01/24/23 Deutsche Bank
UnitedHealth price target raised to $617 from $615 at Deutsche Bank
01/18/23 UBS
UnitedHealth price target lowered to $550 from $590 at UBS
01/17/23 Loop Capital
UnitedHealth price target raised to $590 from $575 at Loop Capital
12/12/22 Wells Fargo
Wells Fargo downgrades Nevro to Equal Weight, lowers price target to $43
CI Cigna
$310.37 /

+2.085 (+0.68%)

01/03/23 Wells Fargo
Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355
01/03/23 Wells Fargo
Cigna downgraded to Equal Weight from Overweight at Wells Fargo
11/23/22 Morgan Stanley
Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley
11/23/22 Morgan Stanley
Cigna assumed with an Overweight at Morgan Stanley
CVS CVS Health
$87.06 /

-0.7 (-0.80%)

01/27/23 Lake Street
Medavail price target lowered to $1 from $4 at Lake Street
01/12/23 Piper Sandler
Oak Street could be worth over $49 per share in buyout, says Piper Sandler
01/12/23 Raymond James
Raymond James upgrades Oak Street on potential takeout by CVS
01/10/23 Stifel
Oak Street Health, CVS deal would make sense for both companies, says Stifel
MOH Molina Healthcare
$302.77 /

+2.35 (+0.78%)

01/04/23 Barclays
Molina Healthcare price target lowered to $375 from $400 at Barclays
12/13/22 BofA
Molina Healthcare upgraded to Neutral at BofA on 'high confidence' in EPS growth
12/13/22 BofA
Molina Healthcare upgraded to Neutral from Underperform at BofA
11/07/22 Cowen
Molina Healthcare price target raised to $380 from $371 at Cowen
UNH UnitedHealth
$485.76 /

-0.035 (-0.01%)

MOH Molina Healthcare
$302.77 /

+2.35 (+0.78%)

HUM Humana
$484.92 /

+3.39 (+0.70%)

CVS CVS Health
$87.06 /

-0.7 (-0.80%)

CNC Centene
$74.70 /

-0.52 (-0.69%)

CI Cigna
$310.37 /

+2.085 (+0.68%)

UNH UnitedHealth
$485.76 /

-0.035 (-0.01%)

HUM Humana
$484.92 /

+3.39 (+0.70%)

CVS CVS Health
$87.06 /

-0.7 (-0.80%)

CNC Centene
$74.70 /

-0.52 (-0.69%)

CI Cigna
$310.37 /

+2.085 (+0.68%)

UNH UnitedHealth
$485.76 /

-0.035 (-0.01%)

MOH Molina Healthcare
$302.77 /

+2.35 (+0.78%)

HUM Humana
$484.92 /

+3.39 (+0.70%)

CVS CVS Health
$87.06 /

-0.7 (-0.80%)

CNC Centene
$74.70 /

-0.52 (-0.69%)

CI Cigna
$310.37 /

+2.085 (+0.68%)

UNH UnitedHealth
$485.76 /

-0.035 (-0.01%)

MOH Molina Healthcare
$302.77 /

+2.35 (+0.78%)

HUM Humana
$484.92 /

+3.39 (+0.70%)

CVS CVS Health
$87.06 /

-0.7 (-0.80%)

CNC Centene
$74.70 /

-0.52 (-0.69%)

CI Cigna
$310.37 /

+2.085 (+0.68%)

Yesterday
Options
Early notable gainers among liquid option names on January 30th » 09:55
01/30/23
01/30
09:55
01/30/23
09:55
CINF

Cincinnati Financial

$108.22 /

+2.85 (+2.70%)

, HUM

Humana

$490.64 /

+9.11 (+1.89%)

, ORLY

O'Reilly Automotive

$784.39 /

+12.91 (+1.67%)

, CL

Colgate-Palmolive

$72.81 /

+1.21 (+1.69%)

, AZO

AutoZone

$2,415.49 /

+44.07 (+1.86%)

Notable gainers among…

Notable gainers among liquid option names this morning include Cincinnati Financial (CINF) $109.00 +3.56, Humana (HUM) $493.44 +11.75, O'Reilly Automotive (ORLY) $788.95 +17.78, Colgate Palmolive (CL) $73.12 +1.53, and AutoZone (AZO) $2412.76 +43.41.

ShowHide Related Items >><<
ORLY O'Reilly Automotive
$784.39 /

+12.91 (+1.67%)

HUM Humana
$490.64 /

+9.11 (+1.89%)

CL Colgate-Palmolive
$72.81 /

+1.21 (+1.69%)

CINF Cincinnati Financial
$108.22 /

+2.85 (+2.70%)

AZO AutoZone
$2,415.49 /

+44.07 (+1.86%)

CINF Cincinnati Financial
$108.22 /

+2.85 (+2.70%)

01/19/23 BMO Capital
Cincinnati Financial initiated with a Market Perform at BMO Capital
01/10/23 Piper Sandler
Cincinnati Financial price target raised to $100 from $98 at Piper Sandler
12/05/22 MKM Partners
Cincinnati Financial price target raised to $130 from $120 at MKM Partners
09/27/22 BofA
BofA starts Cincinnati Financial at Neutral in challenging environment
HUM Humana
$490.64 /

+9.11 (+1.89%)

01/30/23 Cowen
Evolent Health price target raised to $59 from $57 at Cowen
12/27/22 Piper Sandler
Piper views TriCare T-5 contract awards as neutral for Accolade
12/23/22 Wells Fargo
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
12/23/22 Credit Suisse
TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
ORLY O'Reilly Automotive
$784.39 /

+12.91 (+1.67%)

01/12/23 Wedbush
Wedbush downgrades Advance Auto Parts to Neutral, cuts price target to $145
01/05/23 Wells Fargo
O'Reilly Automotive price target raised to $925 from $850 at Wells Fargo
12/09/22 MKM Partners
O'Reilly Automotive price target raised to $900 from $865 at MKM Partners
11/23/22 Citi
O'Reilly Automotive price target raised to $855 from $770 at Citi
CL Colgate-Palmolive
$72.81 /

+1.21 (+1.69%)

01/30/23 Deutsche Bank
Colgate-Palmolive price target lowered to $84 from $87 at Deutsche Bank
01/30/23 Morgan Stanley
Colgate-Palmolive upgraded to Overweight from Equal Weight at Morgan Stanley
01/13/23 JPMorgan
Colgate-Palmolive price target raised to $86 from $81 at JPMorgan
12/06/22 Deutsche Bank
Colgate-Palmolive price target raised to $87 from $85 at Deutsche Bank
AZO AutoZone
$2,415.49 /

+44.07 (+1.86%)

01/27/23 Citi
AutoZone removed from Focus List at Citi
12/07/22 DA Davidson
AutoZone price target raised to $2,360 from $1,950 at DA Davidson
12/07/22 MKM Partners
AutoZone price target raised to $2,650 from $2,350 at MKM Partners
ORLY O'Reilly Automotive
$784.39 /

+12.91 (+1.67%)

HUM Humana
$490.64 /

+9.11 (+1.89%)

CL Colgate-Palmolive
$72.81 /

+1.21 (+1.69%)

CINF Cincinnati Financial
$108.22 /

+2.85 (+2.70%)

AZO AutoZone
$2,415.49 /

+44.07 (+1.86%)

ORLY O'Reilly Automotive
$784.39 /

+12.91 (+1.67%)

HUM Humana
$490.64 /

+9.11 (+1.89%)

CL Colgate-Palmolive
$72.81 /

+1.21 (+1.69%)

ORLY O'Reilly Automotive
$784.39 /

+12.91 (+1.67%)

HUM Humana
$490.64 /

+9.11 (+1.89%)

CL Colgate-Palmolive
$72.81 /

+1.21 (+1.69%)

CINF Cincinnati Financial
$108.22 /

+2.85 (+2.70%)

AZO AutoZone
$2,415.49 /

+44.07 (+1.86%)

ORLY O'Reilly Automotive
$784.39 /

+12.91 (+1.67%)

HUM Humana
$490.64 /

+9.11 (+1.89%)

CL Colgate-Palmolive
$72.81 /

+1.21 (+1.69%)

AZO AutoZone
$2,415.49 /

+44.07 (+1.86%)

Recommendations
Evolent Health price target raised to $59 from $57 at Cowen » 07:18
01/30/23
01/30
07:18
01/30/23
07:18
EVH

Evolent Health

$31.28 /

+0.095 (+0.30%)

, HUM

Humana

$481.53 /

-17.455 (-3.50%)

Cowen analyst Charles…

Cowen analyst Charles Ryhee raised the firm's price target on Evolent Health (EVH) to $59 from $57 and keeps an Outperform rating on the shares. The analyst updated the firm's to incorporate the recently announced Humana (HUM) contract win and the closing of its NIA acquisition which closed 2 months earlier than our model previously assumed. The Hjumana contract which goes live 2H23, is expected to bring $250M in annualized revenue.

ShowHide Related Items >><<
HUM Humana
$481.53 /

-17.455 (-3.50%)

EVH Evolent Health
$31.28 /

+0.095 (+0.30%)

EVH Evolent Health
$31.28 /

+0.095 (+0.30%)

01/06/23 Piper Sandler
Evolent Health price target raised to $51 from $44 at Piper Sandler
12/05/22 Piper Sandler
Evolent Health price target raised to $44 from $33 at Piper Sandler
11/18/22 Cowen
Evolent Health price target raised to $57 from $52 at Cowen
11/18/22 Piper Sandler
Piper says buy Evolent Health following Magellan Specialty deal
HUM Humana
$481.53 /

-17.455 (-3.50%)

12/27/22 Piper Sandler
Piper views TriCare T-5 contract awards as neutral for Accolade
12/23/22 Wells Fargo
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
12/23/22 Credit Suisse
TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
12/13/22 Goldman Sachs
Humana upgraded to Buy at Goldman Sachs on improved competitive position
HUM Humana
$481.53 /

-17.455 (-3.50%)

EVH Evolent Health
$31.28 /

+0.095 (+0.30%)

HUM Humana
$481.53 /

-17.455 (-3.50%)

HUM Humana
$481.53 /

-17.455 (-3.50%)

EVH Evolent Health
$31.28 /

+0.095 (+0.30%)

HUM Humana
$481.53 /

-17.455 (-3.50%)

Over a week ago
Options
Early notable gainers among liquid option names on January 19th » 09:55
01/19/23
01/19
09:55
01/19/23
09:55
CMA

Comerica

$69.53 /

+3.58 (+5.43%)

, PM

Philip Morris

$101.06 /

+1.82 (+1.83%)

, TFC

Truist Financial

$47.06 /

+1.305 (+2.85%)

, KMI

Kinder Morgan

$18.73 /

+0.37 (+2.02%)

, HUM

Humana

$493.63 /

+9.28 (+1.92%)

Notable gainers among…

Notable gainers among liquid option names this morning include Comerica (CMA) $70.11 +4.17, Philip Morris (PM) $101.78 +2.52, Truist Financial (TFC) $46.84 +1.10, Kinder Morgan (KMI) $18.73 +0.37, and Humana (HUM) $493.80 +9.05.

ShowHide Related Items >><<
TFC Truist Financial
$47.06 /

+1.305 (+2.85%)

PM Philip Morris
$101.06 /

+1.82 (+1.83%)

KMI Kinder Morgan
$18.73 /

+0.37 (+2.02%)

HUM Humana
$493.63 /

+9.28 (+1.92%)

CMA Comerica
$69.53 /

+3.58 (+5.43%)

CMA Comerica
$69.53 /

+3.58 (+5.43%)

01/10/23 Odeon Capital
Comerica upgraded at Odeon Capital
01/03/23 Barclays
Comerica price target lowered to $85 from $87 at Barclays
12/21/22 DA Davidson
DA Davidson upgrades Comerica to Buy on 'compelling' valuation
12/20/22 DA Davidson
Comerica upgraded to Buy from Neutral at DA Davidson
PM Philip Morris
$101.06 /

+1.82 (+1.83%)

01/19/23 Jefferies
Philip Morris upgraded at Jefferies as tobacco sentiment may 'finally' improve
01/19/23 Jefferies
Philip Morris upgraded to Buy from Hold at Jefferies
12/13/22 Citi
Philip Morris resumed with a Neutral at Citi
11/15/22 Argus
Philip Morris upgraded to Buy from Hold at Argus
TFC Truist Financial
$47.06 /

+1.305 (+2.85%)

01/09/23 Jefferies
Truist Financial upgraded to Buy from Hold at Jefferies
01/06/23 Deutsche Bank
Truist downgraded to Hold with $48 target at Deutsche Bank
01/06/23 Deutsche Bank
Truist Financial downgraded to Hold from Buy at Deutsche Bank
01/05/23 BofA
BofA downgrades PNC Financial to Underperform, says EPS defensibility priced in
KMI Kinder Morgan
$18.73 /

+0.37 (+2.02%)

12/08/22 Citi
Kinder Morgan initiated with a Neutral at Citi
10/19/22 Barclays
Kinder Morgan price target lowered to $20 from $21 at Barclays
09/07/22 Goldman Sachs
Kinder Morgan upgraded to Neutral from Sell at Goldman Sachs
08/16/22 Barclays
Kinder Morgan price target raised to $21 from $20 at Barclays
HUM Humana
$493.63 /

+9.28 (+1.92%)

12/27/22 Piper Sandler
Piper views TriCare T-5 contract awards as neutral for Accolade
12/23/22 Wells Fargo
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
12/23/22 Credit Suisse
TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
12/13/22 Goldman Sachs
Humana upgraded to Buy at Goldman Sachs on improved competitive position
TFC Truist Financial
$47.06 /

+1.305 (+2.85%)

PM Philip Morris
$101.06 /

+1.82 (+1.83%)

KMI Kinder Morgan
$18.73 /

+0.37 (+2.02%)

HUM Humana
$493.63 /

+9.28 (+1.92%)

CMA Comerica
$69.53 /

+3.58 (+5.43%)

TFC Truist Financial
$47.06 /

+1.305 (+2.85%)

PM Philip Morris
$101.06 /

+1.82 (+1.83%)

KMI Kinder Morgan
$18.73 /

+0.37 (+2.02%)

HUM Humana
$493.63 /

+9.28 (+1.92%)

TFC Truist Financial
$47.06 /

+1.305 (+2.85%)

PM Philip Morris
$101.06 /

+1.82 (+1.83%)

KMI Kinder Morgan
$18.73 /

+0.37 (+2.02%)

HUM Humana
$493.63 /

+9.28 (+1.92%)

CMA Comerica
$69.53 /

+3.58 (+5.43%)

PM Philip Morris
$101.06 /

+1.82 (+1.83%)

KMI Kinder Morgan
$18.73 /

+0.37 (+2.02%)

HUM Humana
$493.63 /

+9.28 (+1.92%)

Hot Stocks
Evolent Health jumps after announcing expansion of Humana pact » 15:58
01/12/23
01/12
15:58
01/12/23
15:58
EVH

Evolent Health

$31.05 /

+2.31 (+8.04%)

, HUM

Humana

$494.50 /

+1.66 (+0.34%)

Shares of Evolent Health…

Shares of Evolent Health (EVH) were up over 8% or to approximately $31 per share in late day trading on Thursday after announcing it has expanded its partnership with Humana (HUM) in a slides presentation prepared for the JP Morgan Healthcare conference.

ShowHide Related Items >><<
HUM Humana
$494.50 /

+1.66 (+0.34%)

EVH Evolent Health
$31.05 /

+2.31 (+8.04%)

EVH Evolent Health
$31.05 /

+2.31 (+8.04%)

01/06/23 Piper Sandler
Evolent Health price target raised to $51 from $44 at Piper Sandler
12/05/22 Piper Sandler
Evolent Health price target raised to $44 from $33 at Piper Sandler
11/18/22 Cowen
Evolent Health price target raised to $57 from $52 at Cowen
11/18/22 Piper Sandler
Piper says buy Evolent Health following Magellan Specialty deal
HUM Humana
$494.50 /

+1.66 (+0.34%)

12/27/22 Piper Sandler
Piper views TriCare T-5 contract awards as neutral for Accolade
12/23/22 Wells Fargo
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
12/23/22 Credit Suisse
TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
12/13/22 Goldman Sachs
Humana upgraded to Buy at Goldman Sachs on improved competitive position
HUM Humana
$494.50 /

+1.66 (+0.34%)

EVH Evolent Health
$31.05 /

+2.31 (+8.04%)

HUM Humana
$494.50 /

+1.66 (+0.34%)

HUM Humana
$494.50 /

+1.66 (+0.34%)

EVH Evolent Health
$31.05 /

+2.31 (+8.04%)

HUM Humana
$494.50 /

+1.66 (+0.34%)

Options
Humana put volume heavy and directionally bearish » 15:15
01/09/23
01/09
15:15
01/09/23
15:15
HUM

Humana

$484.00 /

-8.65 (-1.76%)

Bearish flow noted in…

Bearish flow noted in Humana with 7,746 puts trading, or 4x expected. Most active are Jan-23 450 puts and Feb-23 450 puts, with total volume in those strikes near 5,000 contracts. The Put/Call Ratio is 3.45, while ATM IV is up over 1 point on the day. Earnings are expected on February 1st.

ShowHide Related Items >><<
HUM Humana
$484.00 /

-8.65 (-1.76%)

HUM Humana
$484.00 /

-8.65 (-1.76%)

12/27/22 Piper Sandler
Piper views TriCare T-5 contract awards as neutral for Accolade
12/23/22 Wells Fargo
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
12/23/22 Credit Suisse
TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
12/13/22 Goldman Sachs
Humana upgraded to Buy at Goldman Sachs on improved competitive position
HUM Humana
$484.00 /

-8.65 (-1.76%)

HUM Humana
$484.00 /

-8.65 (-1.76%)

HUM Humana
$484.00 /

-8.65 (-1.76%)

HUM Humana
$484.00 /

-8.65 (-1.76%)

Hot Stocks
Rite Aid appoints Elizabeth Burr as interim CEO » 07:14
01/09/23
01/09
07:14
01/09/23
07:14
RAD

Rite Aid

$3.46 /

+0.015 (+0.44%)

, HUM

Humana

$492.46 /

+4.845 (+0.99%)

Rite Aid (RAD) announced…

Rite Aid (RAD) announced that its board of directors has appointed Elizabeth Burr, a member of the company's board, as interim CEO, effective immediately. Burr's appointment follows Heyward Donigan's departure from the company as president and CEO, and as a member of the board. Rite Aid has initiated a search to identify a permanent CEO and has retained a leading executive search firm. Burr has extensive experience in the health industry, and proven expertise in innovation, business strategy, retail and brand management. She previously served as VP, head of health ventures and chief innovation officer at Humana (HUM).

ShowHide Related Items >><<
RAD Rite Aid
$3.46 /

+0.015 (+0.44%)

HUM Humana
$492.46 /

+4.845 (+0.99%)

RAD Rite Aid
$3.46 /

+0.015 (+0.44%)

10/03/22 Evercore ISI
Walgreens Boots Alliance price target lowered to $32 from $41 at Evercore ISI
10/03/22 Deutsche Bank
Rite Aid price target lowered to $3 from $4 at Deutsche Bank
09/30/22 Evercore ISI
Rite Aid removed from 'TAP Outperform' list at Evercore ISI, target cut to $4.50
06/03/22 Deutsche Bank
Rite Aid price target raised to $4 from $2 at Deutsche Bank
HUM Humana
$492.46 /

+4.845 (+0.99%)

12/27/22 Piper Sandler
Piper views TriCare T-5 contract awards as neutral for Accolade
12/23/22 Wells Fargo
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
12/23/22 Credit Suisse
TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
12/13/22 Goldman Sachs
Humana upgraded to Buy at Goldman Sachs on improved competitive position
RAD Rite Aid
$3.46 /

+0.015 (+0.44%)

HUM Humana
$492.46 /

+4.845 (+0.99%)

RAD Rite Aid
$3.46 /

+0.015 (+0.44%)

HUM Humana
$492.46 /

+4.845 (+0.99%)

RAD Rite Aid
$3.46 /

+0.015 (+0.44%)

HUM Humana
$492.46 /

+4.845 (+0.99%)

RAD Rite Aid
$3.46 /

+0.015 (+0.44%)

HUM Humana
$492.46 /

+4.845 (+0.99%)

Over a month ago
Recommendations
Piper views TriCare T-5 contract awards as neutral for Accolade » 08:38
12/27/22
12/27
08:38
12/27/22
08:38
ACCD

Accolade

$8.34 /

+0.35 (+4.38%)

, HUM

Humana

$513.55 /

+1.06 (+0.21%)

On December 22, the…

On December 22, the Department of Defense awarded $136B of TriCare T-5 contracts to Humana (HUM) in the East Region and TriWest in the West Region, Piper Sandler analyst Jessica Tassan tells investors in a research note. The analyst views the initial T-5 contracts t outcome as neutral for Accolade (ACCD) and reiterates an Overweight rating on the shares with a $13 price target. Heading into the T-5 contract awards, Accolade had teaming agreements with two of the three managed care organization bidders to provide certain navigation services under the new contracts, says Tassan. She believes the teaming agreements were with Humana and HealthNet. Accolade has worked with TriWest in the past and, a T-5 partnership "remains entirely possible," the analyst contends. Based on the initial T-5 contract awards, Tassan has visibility into Accolade's partnership with Humana in the East Region. She estimates Accolade's T-5 teaming agreement with Humana should generate $4.7M of annualized revenue, or 52% of the $9.0M Select Navigator run-rate.

ShowHide Related Items >><<
HUM Humana
$513.55 /

+1.06 (+0.21%)

ACCD Accolade
$8.34 /

+0.35 (+4.38%)

10/04/22 Needham
Accolade price target raised to $15 from $12 at Needham
10/04/22 Piper Sandler
Accolade positioning intact despite Comcast termination, says Piper Sandler
10/03/22 Canaccord
Accolade price target raised to $15 from $12 at Canaccord
09/08/22 Piper Sandler
Accolade assumed with an Overweight at Piper Sandler
HUM Humana
$513.55 /

+1.06 (+0.21%)

12/23/22 Wells Fargo
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
12/23/22 Credit Suisse
TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
12/13/22 Goldman Sachs
Humana upgraded to Buy at Goldman Sachs on improved competitive position
12/13/22 Goldman Sachs
Humana upgraded to Buy from Neutral at Goldman Sachs
HUM Humana
$513.55 /

+1.06 (+0.21%)

ACCD Accolade
$8.34 /

+0.35 (+4.38%)

HUM Humana
$513.55 /

+1.06 (+0.21%)

HUM Humana
$513.55 /

+1.06 (+0.21%)

ACCD Accolade
$8.34 /

+0.35 (+4.38%)

HUM Humana
$513.55 /

+1.06 (+0.21%)

Recommendations
Humana keeps TRICARE East, Centene loses West region, says Wells Fargo » 11:20
12/23/22
12/23
11:20
12/23/22
11:20
HUM

Humana

$513.78 /

+1.29 (+0.25%)

, CNC

Centene

$82.18 /

-0.04 (-0.05%)

Wells Fargo analyst…

Wells Fargo analyst Stephen Baxter commented on the DHA's award of the next managed care support contracts for the TRICARE East and West regions, telling investors in a research note that Humana's (HUM) contract will cover about 4.6M beneficiaries in 24 states and Washington, D.C., a decline from about 6M beneficiaries and 32 states, driven by the DHA's move to a more balanced two-region model. Baxter, who made no change to the firm's Overweight rating on Humana, notes that the DHS's move was known coming into the award, and says that Centene (CNC) lost the TRICARE West region, though there is still an opportunity for unsuccessful bidders to protest the award. Baxter made no change to the firm's Equal Weight rating on Centene shares.

ShowHide Related Items >><<
HUM Humana
$513.78 /

+1.29 (+0.25%)

CNC Centene
$82.18 /

-0.04 (-0.05%)

HUM Humana
$513.78 /

+1.29 (+0.25%)

12/23/22 Credit Suisse
TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
12/13/22 Goldman Sachs
Humana upgraded to Buy at Goldman Sachs on improved competitive position
12/13/22 Goldman Sachs
Humana upgraded to Buy from Neutral at Goldman Sachs
12/01/22 Craig-Hallum
Craig-Hallum upgrades eHealth to Buy on 'clear signs of life'
CNC Centene
$82.18 /

-0.04 (-0.05%)

12/14/22 Argus
Centene price target raised to $99 from $95 at Argus
12/13/22 BofA
Centene downgraded to Underperform from Neutral at BofA
11/23/22 Morgan Stanley
CVS Health assumed with an Overweight at Morgan Stanley
HUM Humana
$513.78 /

+1.29 (+0.25%)

CNC Centene
$82.18 /

-0.04 (-0.05%)

HUM Humana
$513.78 /

+1.29 (+0.25%)

CNC Centene
$82.18 /

-0.04 (-0.05%)

HUM Humana
$513.78 /

+1.29 (+0.25%)

CNC Centene
$82.18 /

-0.04 (-0.05%)

HUM Humana
$513.78 /

+1.29 (+0.25%)

CNC Centene
$82.18 /

-0.04 (-0.05%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.